Gerard Griffioen,Tom Van Dooren,Veronica Rojas de la Parra,Arnaud Marchand,Sara Allasia,Amuri Kilonda,Patrick Chaltin
申请号：
US15215750
公开号：
US10117850B2
申请日:
2016.07.21
申请国别(地区):
US
年份:
2018
代理人:
摘要：
This invention provides novel compounds and the novel compounds for use as a medicine, more in particular for the prevention or treatment of neurodegenerative disorders, more specifically certain neurological disorders, such as disorders collectively known as tauopathies, and disorders characterized by cytotoxic α-synuclein amyloidogenesis. The present invention also relates to the use of said novel compounds for the manufacture of medicaments useful for treating such neurodegenerative disorders. The present invention further relates to pharmaceutical compositions including said novel compounds and to methods for the preparation of said novel compounds.
